Author
Listed:
- Marleen van Oosten
(University of Groningen, University Medical Center Groningen (UMCG)
BioOptical Imaging Center, University of Groningen, UMCG)
- Tina Schäfer
(Institut für Molekulare Infektionsbiologie, Universität Würzburg)
- Joost A. C. Gazendam
(University of Groningen, University Medical Center Groningen (UMCG)
Medical Center Alkmaar)
- Knut Ohlsen
(Institut für Molekulare Infektionsbiologie, Universität Würzburg)
- Eleni Tsompanidou
(University of Groningen, University Medical Center Groningen (UMCG))
- Marcus C. de Goffau
(University of Groningen, University Medical Center Groningen (UMCG))
- Hermie J. M. Harmsen
(University of Groningen, University Medical Center Groningen (UMCG))
- Lucia M. A. Crane
(BioOptical Imaging Center, University of Groningen, UMCG)
- Ed Lim
(Caliper—a PerkinElmer Company)
- Kevin P. Francis
(Caliper—a PerkinElmer Company)
- Lael Cheung
(LI-COR Biosciences)
- Michael Olive
(LI-COR Biosciences)
- Vasilis Ntziachristos
(Technische Universität München & Helmholtz Zentrum)
- Jan Maarten van Dijl
(University of Groningen, University Medical Center Groningen (UMCG))
- Gooitzen M. van Dam
(BioOptical Imaging Center, University of Groningen, UMCG)
Abstract
Invasive and biomaterial-associated infections in humans are often difficult to diagnose and treat. Here, guided by recent advances in clinically relevant optical imaging technologies, we explore the use of fluorescently labelled vancomycin (vanco-800CW) to specifically target and detect infections caused by Gram-positive bacteria. The application potential of vanco-800CW for real-time in vivo imaging of bacterial infections is assessed in a mouse myositis model and a human post-mortem implant model. We show that vanco-800CW can specifically detect Gram-positive bacterial infections in our mouse myositis model, discriminate bacterial infections from sterile inflammation in vivo and detect biomaterial-associated infections in the lower leg of a human cadaver. We conclude that vanco-800CW has a high potential for enhanced non-invasive diagnosis of infections with Gram-positive bacteria and is a promising candidate for early-phase clinical trials.
Suggested Citation
Marleen van Oosten & Tina Schäfer & Joost A. C. Gazendam & Knut Ohlsen & Eleni Tsompanidou & Marcus C. de Goffau & Hermie J. M. Harmsen & Lucia M. A. Crane & Ed Lim & Kevin P. Francis & Lael Cheung & , 2013.
"Real-time in vivo imaging of invasive- and biomaterial-associated bacterial infections using fluorescently labelled vancomycin,"
Nature Communications, Nature, vol. 4(1), pages 1-8, December.
Handle:
RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms3584
DOI: 10.1038/ncomms3584
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms3584. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.